Methods for suppressing an immune response or treating a proliferative disorder

Details for Australian Patent Application No. 2004296868 (hide)

Owner The Government of the United States of America as represented by the Secretary of the Department of Health and Human Services

Inventors Moss, Joel; Kristof, Arnold

Agent Griffith Hack

Pub. Number AU-B-2004296868

PCT Pub. Number WO2005/056014

Priority 60/528,340 09.12.03 US

Filing date 9 December 2004

Wipo publication date 23 June 2005

Acceptance publication date 25 November 2010

International Classifications

A61K 31/496 (2006.01) - Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene

Event Publications

8 June 2006 PCT application entered the National Phase

  PCT publication WO2005/056014 Priority application(s): WO2005/056014

3 August 2006 Change of Name(s) of Applicant(s), Section 104

  The Government of the United State of America as represented by the Secretary of the Department of Health and Human Services The name of the applicant has been changed to The Government of the United States of America as represented by the Secretary of the Department of Health and Human Services

28 August 2008 Amendment Made

  The nature of the amendment is: Amend the invention title to read Methods for suppressing an immune response or treating a proliferative disorder 2005

25 November 2010 Application Accepted

  Published as AU-B-2004296868

24 March 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004296870-Botulinum toxin therapy for skin disorders

2004296863-Synergistic anti-cancer compositions